Discussion with Scientist Pekka Puolasmaa and Project Manager Tuomas Nikula. The goal of gene therapy is to treat or cure severe diseases by carrying genetic material to the target cells to repair the incorrect or …
A conversation with Pirjo Merilahti, PhD., Virology. At Biovian, Viral Vector process development is planned and executed by a team of experienced scientists, led by Dr Pirjo Merilahti. Her team typically starts the project with …
The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …
